Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You are correct about the IPO and others aren't interested in truth or facts, only trying to push an agenda.
The Shelf Offering will occur some time in the next 8 weeks as the company uplists to the NASDAQ.
After that has occurred AMBS will spin off the Diagnostic Division(if it's not sold first) onto the NASDAQ with an IPO.
If folks dig into the companies guiding theses moves they will understand what is about to occur. But most will listen to mindless information posted here instead.
Last time. The company, who actually reports the financials, disagrees with you.
http://m.seekingalpha.com/article/3216786-amarantus-biosciences-ambs-ceo-gerald-commissiong-hosts-business-update-conference-call-transcript?part=single
lol it's clear you make a lot of assumptions that you think are facts...some of which include me who you don't know!
The PPS will tell all in the coming months.
Any by the way the burn rate is closer to 1.2 million now that ESS deal is done and no more options payments need to be made.
They provide a bit more deal here:
http://media.wix.com/ugd/a15970_658970cc43a640239c6174d72e4de2b2.pdf
Therefore I will take their professional opinion over someone on a message board.
Once on the NASDAQ a fair valuation will be set. Don't have long to wait.
Seriously? The OS count is 7+ million with 13.3 million AS. The AS will go to 35 million and those shares will certainly not all enter the float immediately.
Let's at least be logical with what is posted here.
The firms are not pulling the numbers out of the air to make themselves look bad! But you are certainly entitled to your opinion and it won't take long to find out who was correct.
I will let you off cheap with a coke, I don't drink alcohol.
Much better days are ahead here.
Very nice, thanks for sharing the link. People need to remember that AMBS is going to IPO onto the NASDAQ in the very near future, could happen in the next few weeks. So all these firms starting to cover with their price targets will give us an idea of what the PPS will be for the IPO. We have seen targets of $18 and $45.
When the bounce comes it will come quick and yesterday's volume will look small. IMO
That's not possible.
I was just getting ready to say the same....certainly not retailers!!
Yes for the IPO/Shelf offering. That filing has nothing to do with today's volume.
Agreed. Excited only because I don't believe it was retail buying today. And with what's on tap over the next week the PPS could easily continue moving up. We will see but I think we may have finally turned the corner.
lol, not even sure what that means..."did a toxic."
The PPS is moving higher, get use to it. I suspect single digit share price will soon be a thing of the past. This was not retail buying today. IMO
The $$ volume and price action say it all. Closing the ESS acquisition today or tomorrow then AAIC next week.
The shift has began. This is no longer a penny play on the OTC.
Very nice zoom!
Nice 4,000 share buy right before the bell. Looks like someone trying to load up before news and the conference. AAIC starts over the weekend and into next week. Also expecting to hear about the ESS acquisition closing later this week.
On July 8, 2015, the Company exercised its exclusive option to acquire Cutanogen Corporation from Lonza Walkersville, Inc. The Company expects the transaction is expected to close within 5 business days.
That's just not true according to current filings.
http://ir.amarantus.com/all-sec-filings/content/0001144204-15-042059/0001144204-15-042059.pdf
Great to see where the meeting will be held. I actually have plans to be in the city that week, may see if I can adjust my schedule so i can attend the meeting.
However not really thrilled about the other news but also not surprised give the SS and planned IPO. My vote will depend on the news between now and then.
I would like to see some big volume green days on that chart you posted. This would signify positive news has been anounced, great data or revenue news.
Exactly, well stated. The next several weeks are key as I listed last night.
I agree but these type of investors are always protected. This looks like a short term deal and could very well be wiped off the books with the IPO funds.
The IPO is most important!!
Keep in mind this statement. Which says the scenario you made up can't possibly occur because they would exceed the 4.99%.
Each share of our Series G Preferred Stock is convertible into shares of common stock at a conversion price of $9.00 per share at the option of the holder, provided that the holder will be prohibited from converting Series G Preferred Stock into shares of our common stock if, as a result of such conversion, the holder, together with affiliates, would own more than 4.99% of the total shares of our common stock then issued and outstanding.
Also I see you refuse to acknowledge the AMBS has exercised the ESS options....
lol did you miss this:
On July 8, 2015, the Company exercised its exclusive option to acquire Cutanogen Corporation from Lonza Walkersville, Inc. The Company expects the transaction is expected to close within 5 business days.
I agree 100%. This will create the buying pressure that has been missing.
Let's look at what's on tap for the next few weeks:
- next week is the official closing of the ESS acquisition
- the following week AMBS silver sponsor(cost $50k) to announce positive LymPro data at the AAIC
- the last week of July with the share price maintaining above $4 AMBS will qualify for NASDAQ uplist
- that will likely make IPO/uplist in early to mid August raising between $20 million - $150 million with the shelf offering
- mixed in that time frame we get first patient dosing for Eltoprazine Phase 2 trail and ESS Phase 2 trail initiating
Look at my post history, I am not one for predictions but I am gonna say the bottom is in!!
Institutional Investor can NOT convert until the PPS is nearly double the current PPS. That's your definition of toxic....LOL
At most they can get is 241k common shares!
The MFI is trending in the right direction. Pays to follow the money flow especially when the RSI says oversold.
lol great news!!! Conversion PPS is $9
I kinda get your point but do you really expect him to mention AMBS in every article or interview? If he did I would see him as a pumper.
Plus this article appears to be mainly focused on BP listed on the NASDAQ except for one company still listed on the OTC trading at $15 per share.
I did just skim the article. Thanks for posting it.
I don't recall saying all requires. But I understand why you change the argument when proven wrong.
And yes I have better things to do than continue this silly discussion.
AMBS has the money or access to it for the uplist, that's what matter.
We all are very aware of you opinion of Gerald. However most of us don't understand why you repeat it daily on a message board.
I bought shares yesterday and today. Let's check back in 3 weeks (end of July) and see where the PPS is.
This discussion of financing is pointless.
The ihub app says I am up 10,378% today....weeeeee
Right which = $6 per share now. And the PPS has only been under $6 for about a week. So I don't see your point.
ESS is worth more than the current market cap. They would be stupid to not buy down here IF the company requested them to do so.
Here it is from the 10-Q. So please try to keep up and not post wrong information. In this filing they still had $14 million available.
under the financing arrangement as of March 31, 2015.
$14,506 funding remains available
During the first quarter of 2015 under the Lincoln Park Capital Fund LLC financing arrangement the Company sold 38,445,801
common shares and issued 493,436 common shares as a commitment fee for a total of $2,819.
http://ir.amarantus.com/all-sec-filings/content/0001144204-15-032331/0001144204-15-032331.pdf
lol you are hand picking bit and piece in order to support you false statements. Here is my dd
http://seekingalpha.com/article/3216786-amarantus-biosciences-ambs-ceo-gerald-commissiong-hosts-business-update-conference-call-transcript?part=single
You apparently forgot they have $12 million in financing available for LPC thats used to keep that cash on hand for uplist.
You're partly right, they don't have $4 million they have $7 million as of the end of 5/28/15. From the conference call transcript:
On a post-split basis, the share structure meets the NASDAQ requirements. So, we expect that we will have a $4 share price post-split and as Bob mentioned, we have a comfortable margin to ensure that we achieve that. We meet now today the shareholders equity requirements as we have more than $7 million in shareholders’ equity including the Series G, and this is important as we move forward. We do have over a two-year operating history, we have six years. There will be post-split roughly 7 million shares in the public float. We have over 3,000 round lot holders, so we meet that requirement as well. And the value of our publically held shares is well above the $15 million threshold. So right now, today, absent the share price which will soon be corrected post reverse split, we will meet all of those standards required to the NASDAQ. And we can then really start the process moving the company into a marketing phase for the IPO. And this is one of the reasons why we’re doing a number of investor conferences over the next several weeks to really raise the level of interest with both the retail and institutional community as we move forward.
So please provide proof of your statement or quit posting incorrect information.
Let's also not forget about the $725k in federal funding they will have immediate access to from AFIRM. That funding has the potential of being increased to $15 - $20 million.
Lonza has had a muzzle on AMBS regarding this acquisition so i suspect we hear lots more in the coming days once everything is finalize.
Agreed. I believe ESS is worth more than the current market cap, especially when the Phase 2 trail starts.
Great news out in the 8-k!!
Item 8.01 Other Items.
On July 8, 2015, the Company exercised its exclusive option to acquire Cutanogen Corporation from Lonza Walkersville, Inc. The Company expects the transaction is expected to close within 5 business days.